ANESTHESIA FOR THE AGED - SOME PHARMACOKINETIC AND PHARMACODYNAMIC CONSIDERATIONS

被引：0
|
作者：
MILLER, R
机构：
来源：
MOUNT SINAI JOURNAL OF MEDICINE | 1987年 / 54卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：305 / 307
页数：3
相关论文
共 50 条
  • [41] Pharmacokinetic and pharmacodynamic considerations in the treatment of the elderly patient with hypertension
    Peeters, L. E. J.
    Kester, M. P.
    Feyz, L.
    Van den Bemt, P. M. L. A.
    Koch, B. C. P.
    Van Gelder, T.
    Versmissen, J.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (04) : 287 - 297
  • [42] CIGARETTES AND DRUG-THERAPY - PHARMACOKINETIC AND PHARMACODYNAMIC CONSIDERATIONS
    MILLER, LG
    CLINICAL PHARMACY, 1990, 9 (02): : 125 - 135
  • [43] Pharmacokinetic and pharmacodynamic considerations in developing a response to the opioid epidemic
    Balyan, Rajiv
    Hahn, David
    Huang, Henry
    Chidambaran, Vidya
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2020, 16 (02) : 125 - 141
  • [44] Pharmacokinetic and pharmacodynamic considerations for the current chronic constipation treatments
    Mueller-Lissner, Stefan
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (04) : 391 - 401
  • [45] Pharmacokinetic and pharmacodynamic considerations for the next generation protein therapeutics
    Dhaval K. Shah
    Journal of Pharmacokinetics and Pharmacodynamics, 2015, 42 : 553 - 571
  • [46] Therapeutic drug monitoring of antifungals: Pharmacokinetic and pharmacodynamic considerations
    Smith, Deannina
    Andes, David
    THERAPEUTIC DRUG MONITORING, 2008, 30 (02) : 167 - 172
  • [47] PHARMACOKINETIC AND PHARMACODYNAMIC CONSIDERATIONS ON THE CLINICAL USE OF GLUCOSAMINE IN OSTEOARTHRITIS
    Altman, R. D.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 394 - 394
  • [48] Pharmacokinetic and pharmacodynamic considerations of rifamycin antibiotics for the treatment of tuberculosis
    Sekaggya-Wiltshire, Christine
    Dooley, Kelly E.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (08) : 615 - 618
  • [49] Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis
    Berends, Sophie E.
    Strik, Anne S.
    Lowenberg, Mark
    D'Haens, Geert R.
    Mathot, Ron A. A.
    CLINICAL PHARMACOKINETICS, 2019, 58 (01) : 15 - 37
  • [50] Pharmacodynamic and pharmacokinetic considerations in antimicrobial selection: focus on telithromycin
    Drusano, G
    CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 : 24 - 29
12345